ADRB2 and metabolic disease: While our data show that endogenous macrophage B2AR signaling does not regulate local or systemic inflammation in lean and obese states, it might still be stimulated pharmacologically above its physiological threshold level to reduce inflammation and alleviate the severity of metabolic disease.